Why the study?
CMR can overcome limitations of echocardiography in assessing valvular heart disease and regurgitant lesions, motivating a review of its role in assessing disease severity and myocardial remodeling.
Does cardiac magnetic resonance (CMR) improve the assessment of disease severity and myocardial remodeling in patients with valvular heart disease?
Does cardiac magnetic resonance (CMR) improve the assessment of disease severity and myocardial remodeling in patients with valvular heart disease?
Answers are grounded in this paper and cite their sources.
CMR is a valuable imaging modality for assessing disease severity and myocardial remodeling in valvular heart disease, particularly for overcoming limitations of echocardiography in regurgitant lesions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Malahfji et al. (2020) conducted a review in Valvular heart disease. Cardiac magnetic resonance (CMR) imaging vs. Echocardiography was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: